Apeximmune Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
863 Mitten Rd Ste A Unit 161, Burlingame...Website
www.apeximmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Apeximmune Therapeutics
Apeximmune Therapeutics is a biotechnology company focused on developing next-generation immunotherapies for cancer and autoimmune diseases. By leveraging cutting-edge science and a deep understanding of immune mechanisms, the company aims to deliver transformative treatments that improve patient outcomes.Explore more
Apeximmune Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Apeximmune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Apeximmune Therapeutics
Funding: Get notified immidiatlly once Apeximmune Therapeutics has new funding data
Apeximmune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Apeximmune Therapeutics had a recent Job posting/layoffs
Check if Apeximmune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Apeximmune Therapeutics launches new products
Check out if Apeximmune Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Apeximmune Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Apeximmune Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Apeximmune Therapeutics
Compare insights from companies similar to Apeximmune Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Apeximmune Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Apeximmune Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Apeximmune Therapeutics.
Apeximmune Therapeutics financials insights
Gather financial insights about Apeximmune Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$6M
2025
Series A
$21.3M
Apeximmune Therapeutics Tech Stack
A closer look at the technologies used by Apeximmune Therapeutics
Apeximmune Therapeutics News & Media
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation from DCI Partners, Taya Venture Capital, KDI Marketing, Huahai US, Hercules BioVenture LP, and TTM 2025 LLC. We are thrilled [PR.com]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apeximmune Therapeutics
Sign Up For FreeTo access detailed company insights
Apeximmune Therapeutics is a biotechnology company focused on developing next-generation immunotherapies for cancer and autoimmune diseases. By leveraging cutting-edge science and a deep understanding of immune mechanisms, the company aims to deliver transformative treatments that improve patient outcomes.... Read More
